REGENTIS BIOMATERIALS LTD.
HERZLIYA, L3 · CIK 0001912966 · Biotech · Private
Hydrogel platform for tissue repair and regeneration
regentis.co.il →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $6.5M
- 1 Form D · Jun 2026
- 4 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 6 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,500,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1586 | H-CYTE, INC. | — | $11M |
| 1587 | REGENERIX LLC | — | — |
| 1588 | CHEMILY, LLC | — | — |
| 1589 | REGENTIS BIOMATERIALS LTD. | — | $6.5M |
| 1590 | LEXEO Therapeutics LLC | — | — |
| 1591 | THERANOSTEC INC | — | — |
| 1592 | KURE. AI, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Susan AlpertDirector
- Pini Ben-ElazarDirector
- Efraim Cohen-AraziDirector
- Jeff DykanDirector
- Ehud GellerDirector · Executive Officer
- Ori GonExecutive Officer
- Arie GordashnikovExecutive Officer
- Galit ReskeExecutive Officer
- Keith ValentineDirector
Patents
- Organic Solvent Free Compositions Comprising Protein-polymer Conjugates And Uses Thereofapplication
- Organic Solvent Free Compositions Comprising Protein-polymer Conjugates And Uses Thereofgranted
- Compositions Comprising A Polymer-protein Conjugate And An Environmentally-responsive Polymer And Uses Thereofgranted
- Treatments Utilizing A Polymer-protein Conjugateapplication
- Organic Solvent Free Compositions Comprising Protein-polymer Conjugates And Uses Thereofapplication
- Treatment Of Cavities In A Human Bodygranted
- Treatment Of Cavities In A Human Bodygranted
- Matrix Composed Of A Naturally-occurring Protein Backbone Cross Linked By A Synthetic Polymer And Methods Of Generating And Using Samegranted
- Compositions And Methods For Scaffold Formationapplication
- Method of generating a scaffoldapplication
- Pegylated Fibrinogen Precursor Moleculegranted
- Scaffolds Formed From Polymer-protein Conjugates, Methods Of Generating Same And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.